New reports on Iran’s pharmaceutical market show a contradictory picture. On the one hand, the cost of treatment for some diabetic patients has reached 20 million tomans per month, and people are struggling to buy medicine. On the other hand, the value of the pharmaceutical market and the profits of some pharmaceutical companies have increased dramatically.